Literature DB >> 25376942

Proliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1.

Shen Pang1, Jia Shen, Yi Liu, Feng Chen, Zhong Zheng, Aaron W James, Ching-Yun Hsu, Hong Zhang, Kevin S Lee, Chunling Wang, Chenshuang Li, Xuepeng Chen, Haichao Jia, Xinli Zhang, Chia Soo, Kang Ting.   

Abstract

Neural epidermal growth factor-like (NEL)-like protein 1 (NELL-1) has been identified as an osteoinductive differentiation factor that promotes mesenchymal stem cell (MSC) osteogenic differentiation. In addition to full-length NELL-1, there are several NELL-1-related transcripts reported. We used rapid amplification of cDNA ends to recover potential cDNA of NELL-1 isoforms. A NELL-1 isoform with the N-terminal 240 amino acid (aa) residues truncated was identified. While full-length NELL-1 that contains 810 aa residues (NELL-1810 ) plays an important role in embryologic skeletal development, the N-terminal-truncated NELL-1 isoform (NELL-1570 ) was expressed postnatally. Similar to NELL-1810 , NELL-1570 induced MSC osteogenic differentiation. In addition, NELL-1570 significantly stimulated MSC proliferation in multiple MSC-like populations such as murine C3H10T1/2 MSC cell line, mouse primary MSCs, and perivascular stem cells, which is a type of stem cells proposed as the perivascular origin of MSCs. In contrast, NELL-1810 demonstrated only limited stimulation of MSC proliferation. Similar to NELL-1810 , NELL-1570 was found to be secreted from host cells. Both NELL-1570 expression lentiviral vector and column-purified recombinant protein NELL-1570 demonstrated almost identical effects in MSC proliferation and osteogenic differentiation, suggesting that NELL-1570 may function as a pro-osteogenic growth factor. In vivo, NELL-1570 induced significant calvarial defect regeneration accompanied by increased cell proliferation. Thus, NELL-1570 has the potential to be used for cell-based or hormone-based therapy of bone regeneration.
© 2014 AlphaMed Press.

Entities:  

Keywords:  MSC proliferation; NELL-1; Osteogenesis; Secretory protein; Short NELL-1 isoform

Mesh:

Substances:

Year:  2015        PMID: 25376942      PMCID: PMC4410844          DOI: 10.1002/stem.1884

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  58 in total

1.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

Review 2.  Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.

Authors:  Terhi J Heino; Teuvo A Hentunen
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

3.  Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.

Authors:  Catherine M Cowan; Xinquan Jiang; Tiffany Hsu; Chia Soo; Beiji Zhang; Joyce Z Wang; Shun'ichi Kuroda; Benjamin Wu; Zhiyuan Zhang; Xinli Zhang; Kang Ting
Journal:  J Bone Miner Res       Date:  2007-06       Impact factor: 6.741

Review 4.  Human mesenchymal stem cells: from basic biology to clinical applications.

Authors:  B M Abdallah; M Kassem
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

5.  Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.

Authors:  Benedetto Sacchetti; Alessia Funari; Stefano Michienzi; Silvia Di Cesare; Stefania Piersanti; Isabella Saggio; Enrico Tagliafico; Stefano Ferrari; Pamela Gehron Robey; Mara Riminucci; Paolo Bianco
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

6.  Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.

Authors:  Jonas Sjölund; Martin Johansson; Sugata Manna; Carl Norin; Alexander Pietras; Siv Beckman; Elise Nilsson; Börje Ljungberg; Håkan Axelson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 7.  Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation.

Authors:  Laura Fernández-Fernández; Lola Bellido-Martín; Pablo García de Frutos
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249

Review 8.  Recent developments in the biology of fracture repair.

Authors:  Francois N K Kwong; Mitchel B Harris
Journal:  J Am Acad Orthop Surg       Date:  2008-11       Impact factor: 3.020

9.  Active caspase-1 is a regulator of unconventional protein secretion.

Authors:  Martin Keller; Andreas Rüegg; Sabine Werner; Hans-Dietmar Beer
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

10.  Systematic association mapping identifies NELL1 as a novel IBD disease gene.

Authors:  Andre Franke; Jochen Hampe; Philip Rosenstiel; Christian Becker; Florian Wagner; Robert Häsler; Randall D Little; Klaus Huse; Andreas Ruether; Tobias Balschun; Michael Wittig; Abdou Elsharawy; Gabriele Mayr; Mario Albrecht; Natalie J Prescott; Clive M Onnie; Hélène Fournier; Tim Keith; Uwe Radelof; Matthias Platzer; Christopher G Mathew; Monika Stoll; Michael Krawczak; Peter Nürnberg; Stefan Schreiber
Journal:  PLoS One       Date:  2007-08-08       Impact factor: 3.240

View more
  12 in total

1.  NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair.

Authors:  Aaron W James; Jia Shen; Rebecca Tsuei; Alan Nguyen; Kevork Khadarian; Carolyn A Meyers; Hsin Chuan Pan; Weiming Li; Jin H Kwak; Greg Asatrian; Cymbeline T Culiat; Min Lee; Kang Ting; Xinli Zhang; Chia Soo
Journal:  JCI Insight       Date:  2017-06-15

2.  Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone Healing.

Authors:  Soonchul Lee; Chenchao Wang; Hsin Chuan Pan; Swati Shrestha; Carolyn Meyers; Catherine Ding; Jia Shen; Eric Chen; Min Lee; Chia Soo; Kang Ting; Aaron W James
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

3.  Age dependent effects of NELL-1 isoforms on bone marrow stromal cells.

Authors:  Carolyn A Meyers; Zhibo Sun; Leslie Chang; Catherine Ding; Amy Lu; Kang Ting; Shen Pang; Aaron W James
Journal:  J Orthop       Date:  2019-02-28

4.  Reconstructing the Molecular Function of Genetic Variation in Regulatory Networks.

Authors:  Roni Wilentzik; Chun Jimmie Ye; Irit Gat-Viks
Journal:  Genetics       Date:  2017-10-18       Impact factor: 4.562

Review 5.  Perivascular Mesenchymal Progenitors for Bone Regeneration.

Authors:  Aaron W James; Bruno Péault
Journal:  J Orthop Res       Date:  2019-05-17       Impact factor: 3.494

Review 6.  Signaling network regulating osteogenesis in mesenchymal stem cells.

Authors:  Sachin Thomas; Bithiah Grace Jaganathan
Journal:  J Cell Commun Signal       Date:  2021-07-08       Impact factor: 5.782

7.  The Effects of Systemic Therapy of PEGylated NEL-Like Protein 1 (NELL-1) on Fracture Healing in Mice.

Authors:  Justine Tanjaya; Elizabeth L Lord; Chenchao Wang; Yulong Zhang; Jong K Kim; Alan Nguyen; Llyod Baik; Hsin C Pan; Eric Chen; Jin H Kwak; Xinli Zhang; Benjamin Wu; Chia Soo; Kang Ting
Journal:  Am J Pathol       Date:  2017-12-30       Impact factor: 5.770

Review 8.  Alternative splicing in mesenchymal stem cell differentiation.

Authors:  Jung Woo Park; Siyi Fu; Borong Huang; Ren-He Xu
Journal:  Stem Cells       Date:  2020-07-15       Impact factor: 6.277

Review 9.  Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.

Authors:  Antalya Ho-Shui-Ling; Johanna Bolander; Laurence E Rustom; Amy Wagoner Johnson; Frank P Luyten; Catherine Picart
Journal:  Biomaterials       Date:  2018-07-11       Impact factor: 12.479

10.  Rat model of an autologous cancellous bone graft.

Authors:  Tomo Hamada; Hidenori Matsubara; Toshifumi Hikichi; Kanu Shimokawa; Hiroyuki Tsuchiya
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.